MX2012013645A - Procedimiento para la preparacion de pleuromutilinas. - Google Patents

Procedimiento para la preparacion de pleuromutilinas.

Info

Publication number
MX2012013645A
MX2012013645A MX2012013645A MX2012013645A MX2012013645A MX 2012013645 A MX2012013645 A MX 2012013645A MX 2012013645 A MX2012013645 A MX 2012013645A MX 2012013645 A MX2012013645 A MX 2012013645A MX 2012013645 A MX2012013645 A MX 2012013645A
Authority
MX
Mexico
Prior art keywords
formula
compound
preparation
pleuromutilins
intermediates
Prior art date
Application number
MX2012013645A
Other languages
English (en)
Other versions
MX347176B (es
Inventor
Werner Heilmayer
Lee Spence
Rosemarie Riedl
Original Assignee
Nabriva Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag
Publication of MX2012013645A publication Critical patent/MX2012013645A/es
Publication of MX347176B publication Critical patent/MX347176B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Un procedimiento para la preparación de un compuesto de la fórmula I (Ver Formula) en forma de un estereoisómero individual en forma cristalina, que comprende desproteger el grupo amina en un compuesto de la fórmula lla (Ver Formula) o en una mezcla de un compuesto de la fórmula ha con un compuesto de la fórmula lIb (Ver Formula) y aislar un compuesto de la fórmula I de la mezcla de reacción; compuestos y sales de compuestos de la fórmula I en forma cristalina; composiciones farmacéuticas que comprenden dichas sales; procedimientos para la preparación de intermediarios e intermediarios en un procedimiento para la preparación de un compuesto de la fórmula I.
MX2012013645A 2010-05-26 2011-05-23 Procedimiento para la preparacion de pleuromutilinas. MX347176B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20100450092 EP2399904A1 (en) 2010-05-26 2010-05-26 Process for the preparation of pleuromutilins
PCT/AT2011/000237 WO2011146954A1 (en) 2010-05-26 2011-05-23 Process for the preparation of pleuromutilins

Publications (2)

Publication Number Publication Date
MX2012013645A true MX2012013645A (es) 2013-05-01
MX347176B MX347176B (es) 2017-04-17

Family

ID=42937801

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013645A MX347176B (es) 2010-05-26 2011-05-23 Procedimiento para la preparacion de pleuromutilinas.

Country Status (29)

Country Link
US (1) US9120727B2 (es)
EP (3) EP2399904A1 (es)
JP (2) JP6038021B2 (es)
KR (1) KR101935333B1 (es)
CN (2) CN105111117A (es)
AU (1) AU2011257938B2 (es)
BR (1) BR112012029982A2 (es)
CA (1) CA2799029C (es)
DK (2) DK3299356T3 (es)
EA (1) EA023273B1 (es)
ES (2) ES2659729T3 (es)
HK (1) HK1253006A1 (es)
HR (1) HRP20220201T1 (es)
HU (2) HUE035861T2 (es)
IL (1) IL222999A (es)
MA (1) MA34332B1 (es)
MX (1) MX347176B (es)
MY (1) MY164666A (es)
NZ (1) NZ603804A (es)
PL (2) PL3299356T3 (es)
PT (2) PT3299356T (es)
SG (1) SG185104A1 (es)
SI (1) SI3299356T1 (es)
TN (1) TN2012000506A1 (es)
TR (1) TR201802636T4 (es)
TW (1) TWI585073B (es)
UA (1) UA108378C2 (es)
WO (1) WO2011146954A1 (es)
ZA (1) ZA201208056B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法
JP6818019B2 (ja) * 2015-06-17 2021-01-20 ナブリヴァ セラピュティクス ゲーエムベーハー レファムリンの注射可能医薬組成物
WO2016203011A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
PL3701944T3 (pl) 2015-06-18 2022-04-04 Estetra Srl Ulegająca rozpadowi w jamie ustnej jednostka dawkowana zawierająca składnik estetrolowy
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN107417586A (zh) * 2017-06-21 2017-12-01 华南农业大学 一种截短侧耳素类抗生素及其制备方法和应用
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI755055B (zh) 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN111170893B (zh) * 2020-01-19 2022-04-26 郑州依米花手性药物研究有限公司 Lefamulin的中间体化合物及其在Lefamulin制备中的应用
EP4135682A1 (en) 2020-04-17 2023-02-22 Nabriva Therapeutics GMBH Therapeutic use of pleuromutilins
WO2021209173A1 (en) 2020-04-17 2021-10-21 Nabriva Therapeutics GmbH Novel therapeutic use of pleuromutilins
WO2023152115A1 (en) 2022-02-09 2023-08-17 Nabriva Therapeutics GmbH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207370A (ja) * 1985-03-11 1986-09-13 Seitetsu Kagaku Co Ltd 4−(メタンスルホニルオキシ)チオフエノ−ルの製法
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
MXPA05000984A (es) * 2002-07-24 2005-09-12 Sandoz Ag Derivados de pleuromutilina como antimicrobianos.
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
KR100745160B1 (ko) * 2003-08-04 2007-08-01 조인트 스탁 컴퍼니 그린덱스 멜도늄 염, 그것의 제조방법 및 그것을 주성분으로 한약학적 조성물
CA2536144C (en) * 2003-08-18 2010-09-14 H. Lundbeck A/S Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
ES2335284T3 (es) * 2003-09-03 2010-03-24 Glaxo Group Limited Nuevo procedimiento para preparar derivados de pleuromutilina.
CA2659987A1 (en) 2006-07-20 2008-01-24 Wms Gaming Inc. Wagering game with special-event eligibility feature based on passive game play
EP1908750A1 (en) * 2006-10-05 2008-04-09 Nabriva Therapeutics Forschungs GmbH Process for the preparation of pleuromutilins
SI1961735T1 (sl) * 2007-02-22 2010-01-29 Indena Spa Postopek za pripravo acetatne soli (2r,3s)-3-fenilizoserin-metilestra
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
EP2159220A1 (en) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds

Also Published As

Publication number Publication date
US9120727B2 (en) 2015-09-01
US20130079400A1 (en) 2013-03-28
TWI585073B (zh) 2017-06-01
ZA201208056B (en) 2014-01-29
BR112012029982A2 (pt) 2020-09-01
EP2576505B1 (en) 2017-11-29
CA2799029A1 (en) 2011-12-01
SG185104A1 (en) 2012-12-28
MA34332B1 (fr) 2013-06-01
PL2576505T3 (pl) 2018-05-30
DK2576505T3 (en) 2018-03-05
MX347176B (es) 2017-04-17
EA201291370A1 (ru) 2013-09-30
JP2013528162A (ja) 2013-07-08
EP2576505A1 (en) 2013-04-10
CN103080083B (zh) 2016-03-02
EP3299356B1 (en) 2021-11-24
EA023273B1 (ru) 2016-05-31
DK3299356T3 (da) 2022-01-31
KR101935333B1 (ko) 2019-01-04
PL3299356T3 (pl) 2022-04-04
AU2011257938B2 (en) 2016-06-23
JP2016210804A (ja) 2016-12-15
NZ603804A (en) 2014-03-28
CA2799029C (en) 2019-01-29
HK1253006A1 (zh) 2019-06-06
MY164666A (en) 2018-01-30
IL222999A0 (en) 2013-02-03
TW201209026A (en) 2012-03-01
CN105111117A (zh) 2015-12-02
HUE057587T2 (hu) 2022-05-28
PT2576505T (pt) 2018-03-05
WO2011146954A1 (en) 2011-12-01
IL222999A (en) 2016-02-29
CN103080083A (zh) 2013-05-01
EP2399904A1 (en) 2011-12-28
EP3299356A1 (en) 2018-03-28
KR20130079406A (ko) 2013-07-10
SI3299356T1 (sl) 2022-05-31
ES2659729T3 (es) 2018-03-19
JP6501742B2 (ja) 2019-04-17
TR201802636T4 (tr) 2018-03-21
UA108378C2 (uk) 2015-04-27
HUE035861T2 (hu) 2018-06-28
HRP20220201T1 (hr) 2022-04-29
PT3299356T (pt) 2022-02-21
TN2012000506A1 (en) 2014-04-01
ES2909198T3 (es) 2022-05-05
JP6038021B2 (ja) 2016-12-07

Similar Documents

Publication Publication Date Title
TN2012000506A1 (en) Process for the preparation of pleuromutilins
MX340214B (es) Procedimiento para la preparación de compuestos útiles como inhibidores del transportador de glucosa dependiente de sodio 2.
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
SG158829A1 (en) New process for the synthesis of agomelatine
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
MX2013000295A (es) Procedimiento de preparacion de un inhibidor especifico de la trombina.
GEP20125512B (en) Process for synthesis of agomelatin
NZ595591A (en) Processes for the preparation of morphinane and morphinone compounds
MX2011011776A (es) Nuevos profarmacos de triptolite.
IN2012DN04868A (es)
AU2011380449A8 (en) Iodination process for the preparation of 3,5-disubstituted-2,4,6-triiodo aromatic amines compounds
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MY144746A (en) Process for the preparation of agomelatine
UA105843C2 (uk) Спосіб одержання кремнієвмісних азодикарбамідів
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
IN2012DN03104A (es)
GB201104203D0 (en) Chemical process
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
GEP20156350B (en) New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
MX2013002656A (es) Nuevo proceso.
MX2013004425A (es) Preparacion diastereoselectiva de los compuestos de biciclo [2.2.2] octan-2-ona.
GB2511240A (en) Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof

Legal Events

Date Code Title Description
FG Grant or registration